LAB vs LI · rev $174.4M vs P/E 24, rev $16.06B
Standard Biotools Inc (LAB) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
LAB currently screens at market cap $317.1M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the LAB and LI stock pages for the full models.
Not investment advice.